Blueprint Medicines Corporation Analytics - Traffic, Statistics and Competitor Tracking


Blueprint Medicines Corporation Website Screenshot

http://www.blueprintmedicines.com

Blueprint Medicines Corporation Company Intro

Protein kinases (enzymes that modify the functions of proteins) are critical to controlling biochemical pathways and are involved in many hallmarks of tumor biology – yet currently approved drugs focus on less than 5% of known kinases.

Industry

Healthcare

Blueprint Medicines Corporation Headquaters

45 Sidney Street
Cambridge,02139
United States


Blueprint Medicines Corporation Share price

26 Oct 2020 01:14 GMT

$103.71

0.89 (0.87 %)


Blueprint Medicines Corporation Market cap

$5.785 B


WMC RANKING

2020

Blueprint Medicines Corporation # 70

Biotechnology



Latest Blueprint Medicines Corporation News

News 25 Oct 2020

The Week Ahead In Biotech: Kala FDA Decision, Merck ...

The FDA is scheduled to rule on Kala Pharmaceuticals Inc's (NASDAQ: KALA) NDA for ... Blueprint Medicines Corp (NASDAQ: BPMC) (before the market open)

News 25 Oct 2020

Global Gastrointestinal Stromal Tumor (GIST) Drug Market ...

Astex Pharmaceuticals, Inc. Blueprint Medicines Corporation; Boston Biomedical, Inc. Calithera Biosciences, Inc. Chipscreen Biosciences Ltd; Deciphera ...

News 26 Oct 2020

Fibrodysplasia Ossificans Progressiva Drug Market Size 2020 By Product Types, End-Users, Regional Outlook, Growth, Trends And Forecast To 2027 | Market Research Intellect

Blueprint Medicines Corp; Clementia Pharmaceuticals Inc; Daiichi Sankyo Company Ltd; La Jolla Pharmaceutical Company; Oncodesign Sa; Pfizer Inc ...

WMC Market Score


WMC Market to Revenue Score


Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Blueprint Medicines Corporation 1.20 2.83 8.65 0 0 0 8.76
Alexion Pharmaceuticals, Inc. 100 13.26 100 18 0 0 100
Vertex Pharmaceuticals Incorporated 97.58 100 4.09 25 0 0 98.33
3SBio Inc. 96.05 0 0 4 0 0 2.80
Incyte Corporation 40.27 14.26 7.21 100 0 0 92.34

Blueprint Medicines Corporation Market Financials


Revenue, Expenses, Profit


Company Revenue Expense Profit Market Cap WMC Sector Score
Blueprint Medicines Corporation $66,512 $427,838 $-347,694 $5.785B 70
Alexion Pharmaceuticals, Inc. $5,536,800 $2,523,000 $846,100 $26.654B 1
Vertex Pharmaceuticals Incorporated $5,402,685 $2,634,428 $2,080,775 $55.11B 2
3SBio Inc. ¥5,318,091 ¥3,085,221 ¥973,717 ¥19.42B 3
Incyte Corporation $2,229,409 $1,622,822 $446,906 $19.615B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Blueprint Medicines Corporation Social Followers vs Top 4 Industry Competitors



Blueprint Medicines Corporation Post vs Top 4 Industry Competitors


Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries